This poster presents strong scientific evidence that monoclonal antibodies raised against beta glucans from MRL´s Pleurotus ostreatus also recognize beta glucans from other MRL products which is very interesting regarding their tertiary structure. The importance of the tertiary structure of beta-glucans is due to the fact that all beta-glucans with anti-tumor activity exhibited this tertiary structure. (Presented at the 12th International Chemical and Biological Engineering Conference (CHEMPOR 2014), organized by the Department of Chemical Engineering of the Faculty of Engineering - University of Porto and Ordem dos Engenheiros (the Portuguese Engineers Association), held in Porto, Portugal, between the 10th and 12th of September, 2014
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.Clinical articles
-
Hericium erinaceus and Coriolus versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury
Ramona D’Amico 1,†, Angela Trovato Salinaro 2,†, Roberta Fusco 1,†, Marika Cordaro 3, Daniela Impellizzeri 1, Maria Scuto 2, Maria Laura Ontario 2, Gianluigi Lo Dico 2, Salvatore Cuzzocrea 1,4,*, Rosanna Di Paola 1,*, Rosalba Siracusa 1,‡ and Vittorio Calabrese 2,‡ -
Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells
Ines Amara (1)(2), Maria Scuto (2), Agata Zappalà (2), Maria Laura Ontario (2), Antonio Petralia (3), Alwa Abid -Essefi (1), Luigi Maiolino (3), Anna Signorile (4), Angela Trovato Salinaro (2) and Vittorio Calabrese (2). -
Effect of combined therapy polyhexamethylene biguanide and Coriolus-MRL on human papilloma virus (HPV) cervical and vulvar-related lesions
D. Gincheva(1), V. Gincheva(2), E. Konova(1)
-
Nutritional Mushroom Treatment in Meniere’s Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration
Maria Scuto (1),y , Paola Di Mauro (2),y, Maria Laura Ontario (1), Chiara Amato (2), Sergio Moda_eri (1), Domenico Ciavardelli (3,4), Angela Trovato Salinaro (1), Luigi Maiolino (2),* and Vittorio Calabrese (2)